Hypothesis

Aging triggers oxidative stress–dependent phosphorylation of METTL3 and METTL14, promoting their export from the nucleus to the cytoplasm. Once cytoplasmic, these m6A writers aberrantly methylate not only core autophagy transcripts (ULK1, ATG5, ATG7, TFEB) but also the mRNA encoding the mitophagy regulator PINK1. This dual hit suppresses both general autophagy and selective mitochondrial clearance, leading to the accumulation of damaged mitochondria and the formation of neuromelanin‑laden autolysosomes observed in aged neurons.

Mechanistic Model

• Nuclear loss: In young neurons, METTL3/14 reside predominantly in the nucleus, where they methylate synaptic‑gene transcripts to support plasticity (2).
• Stress‑induced export: Age‑related ROS activates kinases (e.g., AKT, ERK) that phosphorylate METTL3/14 on serine residues, exposing a nuclear export signal and facilitating CRM1/XPO1‑mediated transport to the cytoplasm (1).
• Cytoplasmic hypermethylation: Cytoplasmic METTL3/14 deposit m6A on autophagy and PINK1 transcripts, recruiting YTHDF2 which drives their decay (3,4).
• Compensatory YTHDF3 activity: While YTHDF3 can enhance FOXO3 translation and modestly stimulate autophagy (6), its effect is insufficient to overcome the dominant YTHDF2‑mediated decay of autophagy and mitophagy mRNAs.
• Outcome: Reduced PINK1 limits Parkin‑mediated mitophagy, causing mitochondrial ROS production that further fuels METTL3/14 phosphorylation—a vicious cycle. The resulting autophagic stall manifests as enlarged, undegraded autolysosomes (neuromelanin organelles) (7).

Testable Predictions

1. Inhibiting CRM1/XPO1 with Leptomycin B in aged human iPSC‑derived neurons will restore nuclear METTL3/14 localization, decrease m6A on ULK1/ATG5/PINK1 transcripts, and increase autophagic flux.
2. Phospho‑deficient mutants of METTL3/14 (Ser→Ala) resistant to oxidative‑stress kinases will remain nuclear in aged mice, preserving autophagy and reducing neuromelanin accumulation.
3. Overexpressing a cytoplasmic‑restricted, catalytically dead METTL3 will act as a dominant‑negative, sequestering YTHDF2 and rescuing autophagy despite endogenous mislocalization.
4. In aged METTL3/14 phospho‑mutant mice, mitochondrial membrane potential and ROS levels will be comparable to young controls, linking autophagic rescue to improved mitochondrial homeostasis.

Experimental Approach

• Generate CRISPR‑edited human iPSC lines expressing METTL3‑S202A/METTL14‑S186A (phospho‑deficient) and differentiate to cortical neurons.
• Treat aged neurons (≥60 days in culture) with Leptomycin B or vehicle; assess subcellular fractionation by western blot for METTL3/14 (1).
• Perform MeRIP‑seq to quantify m6A on ULK1, ATG5, ATG7, TFEB, and PINK1 transcripts (3,4).
• Measure autophagic flux using LC3‑II turnover with bafilomycin A1 and mitophagy using mt‑Keima reporter.
• Quantify neuromelanin‑positive autolysosomes via immunofluorescence and electron microscopy (7).
• In parallel, aged wild‑type and phospho‑mutant mice will undergo behavioral testing (Morris water maze) and histology for neuromelanin and mitochondrial markers.

If nuclear retention or catalytic blockade of METTL3/14 restores autophagy and reduces neuromelanin, the hypothesis that age‑dependent cytoplasmic sequestration of m6A writers actively suppresses autophagy—and thereby contributes to neurodegenerative accumulation—will be supported. Conversely, failure to rescue autophagy despite nuclear relocation would falsify the model, indicating that additional downstream blocks dominate the autophagic stall in aging.